SIRNAOMICS-B_Providing professional financial news and data related to SIRNAOMICS-B, committed to creating a comprehensive and efficient information access channel for users | NewTimeSpace

SIRNAOMICS-B (02257.HK): Deemed disposal of equity interest in subsidiary following RMB 30 million investment, repurchase right granted to investor

Tags：

SIRNAOMICS-B 02257.HK Disposal

2026-08-26

SIRNAOMICS-B (02257.HK): Completes subscription of 2,435,600 new shares, net proceeds of approximately HKD 11.3 million for working capital

Tags：

SIRNAOMICS-B 02257.HK H-share placement

2026-08-12

Sirnaomics-B (02257.HK): First Patient Dosed in Phase 2 Clinical Trial of STP705 for Medical Aesthetics

Tags：

SIRNAOMICS-B 02257.HK Medical Aesthetics Clinical Trial

2026-07-30

SIRNAOMICS-B (02257.HK): Establishes External Scientific Advisory Board with Five Renowned International Interdisciplinary Experts Onboard

Tags：

SIRNAOMICS-B 02257.HK Scientific Advisory Board

2026-07-21

Sirnaomics-B (02257.HK) Chairman Dr. Patrick Lu Acquires 20,300 Shares, Stake Rises to 16.12%

Tags：

SIRNAOMICS-B 02257.HK Acquires

2026-06-24

SIRNAOMICS-B (02257.HK) plans to issue in total 2.44 million shares by subscription, with estimated net proceeds of HKD 11.3 million

Tags：

SIRNAOMICS-B 02257.HK Share Issue

2026-05-26

Scan QR Code

Download App